Clinical Trial Update: TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial [Phase 3]

View source ↗

Summary

The TROPHY Phase 3 trial evaluating candesartan cilexetil for long-term prevention of hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Atacand (candesartan)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Phase 3 | Status: COMPLETED